contents global navigation copyrights
Menu

Technology (R&D)

Intellectual property/Certification

9 IPs related to Prostate cancer genetic test and AI Software-as a medical device for prostate biopsy decision-making in PSA grey zone.(7 registered, 2 applied)

  1. 1Ethnic-specific Prostate Cancer Genetic Risk Score Calculating Device, Calculating Method and Recording Medium (Registered)
  2. 2Prostate cancer genetic risk score calculating device, calculating method and recording medium (Registered)
  3. 3Prostate cancer risk score calculator, and method of the above calculator (Registered)
  4. 4System for predicting a direction of prostate cancer risk (Registered)
  5. 5Device, Calculating Method of Calculating Ethnic-specific Prostate Cancer Genetic Risk Score Considering the Predictive Power According to the Number of Genetic Variations and Recording Medium (Registered)
  6. 6Device, Method of Calculating Prostate Cancer Genetic Risk Score Based on Individual Weights for each Genetic Variation and Recording Medium (Registered)
  7. 7Apparatus and method for calculating risk of prostate cancer based on machine learning, Apparatus and method for generating risk calculation model of prostate cancer based on machine learning (Registered)
  8. 8Prostate Cancer Genetic Risk Score Calculating Device, Calculating Method and Recording Medium
  9. 9Method for determining subject for prostate biopsy and device using the same
Rights classification(domestic and foreign patents / a utility model) Registration (application) name Registration (application) date Registration (application) number Registration (application) person
Domestic patent registration Ethnic-specific Prostate Cancer Genetic Risk Score Calculating Device, Calculating Method and Recording Medium 2020.01.15 10-2068666 PROCAGEN corporation
Domestic patent registration Prostate cancer genetic risk score calculating device, calculating method and recording medium 2020.01.15 10-2068667 PROCAGEN corporation
Domestic patent registration Prostate cancer risk score calculator, and method of the above calculator 2020.04.14 10-2102848 PROCAGEN corporation, Seoul National University Industrial-Academic Cooperation Group
Domestic patent registration System for predicting a direction of prostate cancer risk 2021.09.10 10-2303272 PROCAGEN corporation, Seoul National University Industrial-Academic Cooperation Group, Bundang Seoul National University Hospital,
Domestic patent registration Device, Calculating Method of Calculating Ethnic-specific Prostate Cancer Genetic Risk Score Considering the Predictive Power According to the Number of Genetic Variations and Recording Medium 2022.03.02 10-2371654 PROCAGEN corporation
Domestic patent registration Device, Method of Calculating Prostate Cancer Genetic Risk Score Based on Individual Weights for each Genetic Variation and Recording Medium 2022.03.02 10-2371655 PROCAGEN corporation
Domestic patent registration Apparatus and method for calculating risk of prostate cancer based on machine learning, Apparatus and method for generating risk calculation model of prostate cancer based on machine learning 2023.03.24 10-2515437 Bundang Seoul National University Hospital, PROCAGEN corporation
Patent application in Korea Prostate Cancer Genetic Risk Score Calculating Device, Calculating Method and Recording Medium 2021.12.28 10-2021-0189135 PROCAGEN corporation
Patent application in Korea Method for determining subject for prostate biopsy and device using the same 2022.10.24 10-2022-0137728 PROCAGEN corporation
  • patent
  • patent
  • patent
  • patent
  • patent
  • patent
  • patent

Certification

  1. 1 Certificate of declaration by genetic testing institution
  2. 2 Certificate of quality evaluation of genetic testing institution
Authentication name Competent authority Certification Date
Cerificate of declaration by genetic testing institution Korea Centers for Disease Control and Prevention 26/10/2021
Certification of quality evaluation of genetic testing institution Korea Institute of Genetic Testing and Evaluation 30/12/2022